August 2012 — RLH is pleased to announce its acquisition of DCRX Infusion, a leading provider of customized nutritional therapy to patients with end stage renal disease. DCRX, based in Sunrise, Florida, provides products and services to dialysis centers on a nationwide basis. RLH is privileged to partner in this investment with Robert Funari, an experienced healthcare executive with a successful background in building specialty pharmaceutical companies. Prior to partnering with RLH, Bob was CEO of Crescent Healthcare and of Syncor International. DCRX assists dialysis patients who are at higher risk of adverse clinical outcomes because of chronic malnutrition. The Company's skilled clinicians work with referring nephrologists to formulate and deliver the appropriate parenteral nutrition therapy for each patient. DCRX also provides a team of pharmacists, nurses, and dieticians that offer comprehensive clinical consulting support for dialysis centers and their patients. Through this combination of customization and responsive service, the Company has achieved exceptional growth.